InspireMD (FRA:II2) 3-Year EBITDA Growth Rate : 49.70% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is InspireMD 3-Year EBITDA Growth Rate?

InspireMD's EBITDA per Share for the three months ended in Dec. 2023 was €-0.16.

During the past 3 years, the average EBITDA Per Share Growth Rate was 49.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 67.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of InspireMD was 88.10% per year. The lowest was 49.70% per year. And the median was 73.70% per year.

Competitive Comparison of InspireMD's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, InspireMD's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InspireMD's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where InspireMD's 3-Year EBITDA Growth Rate falls into.

InspireMD 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

InspireMD (FRA:II2) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

InspireMD 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of InspireMD's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

InspireMD (FRA:II2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (FRA:II2) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

NSPR:USA

Address

4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832

Website

https://www.inspiremd.com

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

InspireMD (FRA:II2) Headlines

No Headlines